Zobrazeno 21 - 30
of 199
pro vyhledávání: '"Capuano, A."'
Autor:
Maria Amicone, Pasquale Buonanno, Eleonora Riccio, Monica Franzese, Antonio Pisani, Ivana Capuano, Lucia Ferreri, Mario Zanfardino
Publikováno v:
MOLECULAR GENETICS & GENOMIC MEDICINE (2021). doi:10.1002/mgg3.1659
info:cnr-pdr/source/autori:Eleonora Riccio; Mario Zanfardino; Monica Franzese; Ivana Capuano; Pasquale Buonanno; Lucia Ferreri; Maria Amicone; Antonio Pisani;/titolo:Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol/doi:10.1002%2Fmgg3.1659/rivista:MOLECULAR GENETICS & GENOMIC MEDICINE/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine, Vol 9, Iss 5, Pp n/a-n/a (2021)
info:cnr-pdr/source/autori:Eleonora Riccio; Mario Zanfardino; Monica Franzese; Ivana Capuano; Pasquale Buonanno; Lucia Ferreri; Maria Amicone; Antonio Pisani;/titolo:Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol/doi:10.1002%2Fmgg3.1659/rivista:MOLECULAR GENETICS & GENOMIC MEDICINE/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine, Vol 9, Iss 5, Pp n/a-n/a (2021)
Background Although enzyme replacement therapy with agalsidase beta resulted in a variety of clinical benefits, life‐long biweekly intravenous infusion may impact on patients’ quality of life. Moreover, regular infusions are time‐consuming: alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6687bf2946b9aaefd9e5af7126823f00
http://www.scopus.com/record/display.url?eid=2-s2.0-85102850522&origin=inward
http://www.scopus.com/record/display.url?eid=2-s2.0-85102850522&origin=inward
Autor:
Melissa Lamar, Robert S. Wilson, Bryan D. James, David A. Bennett, E. Wesley Ely, Julie A. Schneider, Ana W. Capuano, Raj C. Shah, Patricia A. Boyle
Publikováno v:
Annals of Neurology
OBJECTIVE To test the hypothesis that Alzheimer's disease and related neuropathologies contribute to the association between hospitalization and cognitive decline in old age. METHODS As part of a longitudinal clinical-pathologic cohort study, 526 old
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
The high mortality observed in Covid-19 patients may be related to unrecognized pulmonary embolism, pulmonary thrombosis, or other underlying cardiovascular diseases. Recent data have highlighted that the mortality rate of Covid-19 seems to be higher
Publikováno v:
Pharmacological Research
Taking anti-inflammatory drugs, including non-steroidal (NSAIDs), during Covid-19 infection, how much is risky? The French Minister of Health, who has raised an alarm on a possible risk deriving from the use of ibuprofen for the control of fever and
Autor:
Daniela Cristiano, Maria Rosaria Carullo, Yolande Therese Rose Proroga, Nicoletta Murru, Federico Capuano, Maria Francesca Peruzy
Publikováno v:
Antibiotics
Volume 9
Issue 7
Antibiotics, Vol 9, Iss 365, p 365 (2020)
Volume 9
Issue 7
Antibiotics, Vol 9, Iss 365, p 365 (2020)
The continuous collection and analysis of updated data on the antimicrobic resistance among bacterial strains represent the essential core for the surveillance of this problem. The present work aimed to investigate the occurrence of antimicrobial res
Autor:
Giorgio Racagni, Alice Zoccoli, Simona Brusco, Liberato Berrino, Michele Bertini, Francesco Rossi, Concetta Rafaniello, Cristina Scavone, Liberata Sportiello, Annalisa Capuano
Publikováno v:
British Journal of Pharmacology
Since December 2019 SARS-Cov-2 was found responsible for the disease COVID-19, which has spread worldwide. No specific therapies/vaccines are yet available for the treatment of COVID-19. Drug repositioning may offer a strategy and a number of drugs h
Autor:
Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, Carmen Ferrajolo, Giorgio Racagni, Liberato Berrino, Giuseppe Paolisso, Francesco Rossi, Annalisa Capuano
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Although clinical manifestations of the 2019 novel coronavirus disease pandemic (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), are mainly respiratory symptoms, patients can also develop severe cardiovasc
Autor:
Cristina Scavone, Annamaria Mascolo, Rosanna Ruggiero, Liberata Sportiello, Concetta Rafaniello, Liberato Berrino, Annalisa Capuano
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background: The use of quinolones has been associated with the development of serious and persistent adverse drug reaction mainly affecting muscles, joints and the nervous system. This risk has led the European Medicines Agency (EMA) to endorse some
Publikováno v:
International immunopharmacology, 84:106519
International Immunopharmacology
International Immunopharmacology
The new coronavirus outbreak is an ongoing pandemic that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new coronavirus SARS-Cov-2 belongs to the subfamily of β–coronaviruses and shares 79.5% of the genetic sequence
Autor:
Chiara Agrati, Belinda Palermo, Massimo Sanchez, Floriana Iacobone, Mauro Biffoni, Rita Casetti, Giorgio Fedele, Francesca Urbani, Valentina La Sorsa, Pasqualina Leone, Cristina Capuano, Marianna Nuti, Helena Stabile, Iole Macchia, Andrea Rozo Gonzalez, Filippo Belardelli, Carla Buccione, Giovanna Schiavoni, Ilaria Grazia Zizzari, Paola Rizza, Maria Carollo, Cinzia Fionda, Matilde Sinibaldi, Irene Ruspantini, Valentina Tirelli, Concetta Quintarelli, Aurelia Rughetti, Paola Nisticò, Roberta Maggio, Angela Gismondi, Stefania Morrone
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2020 (2020)
Journal of Immunology Research, Vol 2020 (2020)
Background. Personalised medicine in oncology needs standardised immunological assays. Flow cytometry (FCM) methods represent an essential tool for immunomonitoring, and their harmonisation is crucial to obtain comparable data in multicentre clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbe1f02cb9e596d34fdb42ef9769b56
http://hdl.handle.net/11573/1386510
http://hdl.handle.net/11573/1386510